bloodstream infection Clinical Trials

7 recruitingLast updated: May 5, 2026

There are 21 actively recruiting bloodstream infection clinical trials across 21 countries. Studies span Not Applicable, Phase 4, Phase 3. Top locations include Montreal, Quebec, Canada, Rozzano, Milan, Italy, Ampang, Selangor, Malaysia. Updated daily from ClinicalTrials.gov.


bloodstream infection Trials at a Glance

21 actively recruiting trials for bloodstream infection are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Montreal, Rozzano, and Ampang. Lead sponsors running bloodstream infection studies include Todd C. Lee MD MPH FIDSA, Hospital de Clinicas de Porto Alegre, and Fudan University.

Browse bloodstream infection trials by phase

Treatments under study

About bloodstream infection Clinical Trials

Looking for clinical trials for bloodstream infection? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new bloodstream infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about bloodstream infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus Aureus BacteraemiaStaphylococcal Bacteraemia+1 more
Region Skane420 enrolled1 locationNCT06726395
Recruiting

INfectious DIsease REgistry BIObank

Bone and joint infectionsInfective EndocarditisCentral Nervous System Infections+4 more
IRCCS San Raffaele10,000 enrolled1 locationNCT06418048
Recruiting
Not Applicable

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland606 enrolled12 locationsNCT06958835
Recruiting
Not Applicable

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

bloodstream infectionGram-negative InfectionsGram-Positive Infections+1 more
Istituto Clinico Humanitas400 enrolled1 locationNCT07491419
Recruiting
Phase 4

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bloodstream Infection
Todd C. Lee MD MPH FIDSA300 enrolled1 locationNCT06650488
Recruiting
Phase 4

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06650501
Recruiting
Phase 4

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+2 more
Todd C. Lee MD MPH FIDSA300 enrolled14 locationsNCT06637332
Recruiting
Not Applicable

Investigational Study With the BD PosiFlush™ SafeScrub on NADs

CRBSI - Catheter Related Bloodstream Infection
Becton, Dickinson and Company220 enrolled2 locationsNCT06604026
Recruiting

Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections

Bloodstream InfectionsBacteremia and SepsisFungemia
Istanbul Medipol University Hospital300 enrolled1 locationNCT07408544
Recruiting
Not Applicable

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

bloodstream infectionGram-negative InfectionsBacteraemia Caused by Gram-Negative Bacteria+1 more
Humanitas University172 enrolled1 locationNCT07372131
Recruiting

Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China

CLABSI - Central Line Associated Bloodstream Infection
Jianfeng Xie1,846 enrolled1 locationNCT07255105
Recruiting
Not Applicable

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

Quality ImprovementCRBSI - Catheter Related Bloodstream InfectionEvidence-based Nursing Practice+4 more
Fudan University8,050 enrolled1 locationNCT06085690
Recruiting
Not Applicable

Advanced Dressings for CVC Infection Prevention in PICU

bloodstream infectionCentral Venous CathetersCatheter-Related Infections+1 more
University of Seville250 enrolled1 locationNCT07175116
Recruiting
Phase 3

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd.80 enrolled1 locationNCT07089186
Recruiting
Phase 4

Optimising TREATment for Severe Gram-Negative Bacterial Infections

bloodstream infectionCarbapenem Resistant Bacterial InfectionMultidrug Resistance+2 more
National University of Singapore600 enrolled41 locationsNCT07004049
Recruiting
Not Applicable

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

bloodstream infection
University Hospital, Antwerp200 enrolled1 locationNCT06576258
Recruiting

Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study

SepsisCritically Ill Intensive Care Unit PatientsBloodstream Infections
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT06791889
Recruiting
Not Applicable

Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU

CLABSI - Central Line Associated Bloodstream Infection
University of Malaya110 enrolled1 locationNCT05959018
Recruiting

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

bloodstream infectionSepsis
Maastricht University Medical Center300 enrolled1 locationNCT06624618
Recruiting

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital

Central Line-associated Bloodstream Infection (CLABSI)
Port Said University600 enrolled2 locationsNCT06458231